Navigation path


The third Partnership Forum of EU Joint Action HA-REACT held in Lisbon (Portugal) on 27 October 2017 gathered 47 participants


The Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT) addresses existing gaps in the prevention of HIV and other co-infections, especially tuberculosis (TB) and viral hepatitis, among people who inject drugs (PWID). The HA-REACT Joint action is co-funded by the Health Programme 2014-2020, Annual Work plan 2014.

The HA-REACT project has been carried out in three focus countries: Latvia, Lithuania and Hungary. In addition, Czech Republic and Poland are focus countries of the prison work package.

During the second year several trainings have taken place in focus countries (Latvia, Lithuania Hungary, Czech Republic and Poland) and training materials have either been published or are in preparation. A remarkable step was taken in Latvia as the mobile unit for testing and needle exchange started to operate. The Czech Republic launched a pilot for distributing condoms in a prison in Prague. A set of best practices to reduce drug-related harm in prison settings in Poland and the Czech Republic has been published.  Manuals for rapid testing of HIV and hepatitis C  for Latvia and Hungary are being drafted. Protocols have been designed for monitoring harm reduction services and conducting national estimates of the number of people who inject drugs (PWID). An achievement worth noticing is that the Polish prison administration has decided on opioid substitution treatment (OST) for all prisoners in need.